InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Anderman Jonathan. Officer active across 1 company, notably Compass Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €69k. Activity tracked since 7 April 2025. The latest transaction was filed on 29 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Anderman Jonathan is a declarant linked to Compass Therapeutics, Inc., where he is General Counsel. He has 3 filings in total, and across the 3 sampled recent filings between 2025-04-08 and 2026-04-30, buys total 68655 EUR and sells total 0 EUR, with a modal transaction nature of Acquisition.